PVLA · Palvella Therapeutics, Inc.

0001193125-26-220607

Summary

Palvella Therapeutics received Nasdaq approval to transfer its common stock listing from Nasdaq Capital Market to Nasdaq Global Market, effective May 13, 2026, with ticker PVLA unchanged.

Key takeaways

Approval received on May 11, 2026 from Nasdaq Listing Qualifications Department.
Listing moves from Nasdaq Capital Market to Nasdaq Global Market.
Effective with open of business on May 13, 2026.
Ticker symbol PVLA remains unaffected.
Signals compliance with higher tier listing standards.

Full analysis

The transfer to the Nasdaq Global Market from the Capital Market tier reflects the Company's fulfillment of stricter listing requirements, potentially enhancing stock visibility and investor appeal. This administrative move, approved prior to the filing date, maintains continuity with the existing PVLA ticker, avoiding any trading disruptions.